https://www.selleckchem.com/mTOR.html
3.3%). Focusing on patients with a minimum follow-up of 12 mo (6/12) or 24 mo (4/12), long-term healing rates were 66.7% (4/6) and 50.0% (2/4), respectively. Data of this single-center experience are promising but limited due to the small number of patients and the retrospective analysis. Data of this single-center experience are promising but limited due to the small number of patients and the retrospective analysis. Liver transplantation (LT) presents a curative treatment option in patients with early stage hepatocellular carcinoma (HCC) who are